NOVEL RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF RESERPINE AND PIPERINE IN POLYHERBAL FORMULATION
HTML Full TextNOVEL RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF RESERPINE AND PIPERINE IN POLYHERBAL FORMULATION
U. D. Jaiswar, R. M. Patil and V. N. Jain *
Department of Quality Assurance, Oriental College of Pharmacy, Sector 2, Sanpada, Navi Mumbai, Maharashtra, India.
ABSTRACT: A novel, simple, accurate, precise, robust High-Performance Liquid Chromatography method was developed to simultaneously estimate reserpine and piperine. This method was applied to standardize polyherbal formulation containing these markers as one of its ingredients. The markers were resolved using Prontosil C-18 column, with mobile phase acetonitrile and water containing 0.05% ortho-phosphoric acid in the ratio 50:50, flow rate of 1 ml/min and detector set at 225 nm. Retention time of reserpine and piperine were found to be 5.4±0.2 min and 13.5 ± 0.2 min, respectively. Linear response was obtained in the tested concentration range of 1 to 20 µg/ml for reserpine and 10 to 100 µg/ml for piperine, with correlation coefficients of 0.999 and 0.998 for reserpine and piperine, respectively. This method can be used to evaluate other formulations containing reserpine and piperine as markers, thus conforming to the need of ensuring safety and quality of herbal formulations.
Keywords: HPLC, Herbal, Standardization, Validation, Reserpine, Piperine
INTRODUCTION: Herbal medicines are polyherbal formulations, and each herb consists of different types of phytoconstituents that may have different medicinal attributes 1. In recent years there has been a rapid increase in herbal product use in developed and developing countries. It is important to ensure herbal medicines' safety and efficacy 2. Standardization is essential in maintaining and assessing the quality of herbal products 3. Modern analytical techniques such as High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), High-Performance Thin-Layer Chromatography (HPTLC), Mass Spectrometry (MS) and others are used in assessing the quality of herbal products 4.
The present study illustrates a novel RP-HPLC method development and validation for detection, quantification, and standardization of reserpine and piperine in marketed polyherbal formulation. The literature survey found that various analytical methods have been developed for the standardization of reserpine and piperine individually or in combination with other components; however, no method is reported for simultaneous estimation of both components (reserpine and piperine). Hence, it was thought worthwhile to develop a novel HPLC method that can be used to standardize polyherbal formulations containing these markers 5-9.
The marketed formulation used in the present study contains several ingredients, mainly Kamla (Nelumbo nucifera), Ashwagandha (Withania somnifera), Arjuna (Terminalia arjuna), Maricha (Piper nigrum), Sarpagandha (Rauwolfia serpentina), Pippali (Piper longum) and others. The selected active constituent reserpine from R. serpentina is a well-known anti-hypertensive constituent 10. Piperine is an alkaloid found in Piper species of Piperaceae family. It increases bioactivity of various therapeutic drugs and phytochemicals because of its inhibitory action on enzymatic drug biotransformation in liver. It also has liver protective activity 11.
MATERIALS AND METHODS:
Marketed Formulation: A commercial preparation Navhridaya Kalpa (Sriveda Sattva Pvt. Ltd) used for analysis was procured from the local market of Mumbai, Maharashtra, India. Each tablet contains 23.26 mg of Sarpagandha, 34.89 mg of Maricha, and 23.26 mg of Pippali.
Requisites: All the chemicals of HPLC grade used were procured from Thermo Fisher Scientific Pvt. Ltd, India. Standards of reserpine and piperine were procured from Sigma-Aldrich Chemicals Pvt. Ltd, India. HPLC-grade water was used for analysis.
Preparation of Standard Solutions: 100 mg of both markers i.e., reserpine and piperine were weighed accurately and transferred to a volumetric flask of 100 ml and volume was then made up with methanol to obtain a solution of 1000 µg/ml. The stock solution was injected in HPLC after suitable dilutions.
Preparation of Sample Solution: 10 tablets of the formulation were triturated and 2 g powder of this tablet mixture was weighed accurately. The weighed powder was subjected to extraction with methanol for 30 minutes using reflux assembly. The refluxed solution was filtered through the Whatman filter paper. The solution was injected after suitable dilutions.
Mode of chromatography | : | Reversed phase chromatography |
Mode of elution | : | Isocratic |
Column | : | Prontosil C-18 column, 5μ (4.6×250 mm) |
Flow rate | : | 1.0 ml/min |
Column oven temperature | : | 28°C |
Wavelength | : | 225 nm |
Column | : | C18 (5µm Particle size, Dimensions: 4.6 x 250 mm) |
Run time | : | 15 min |
Injection volume | : | 20 µl |
Mobile Phase | : | Acetonitrile and water containing 0.05% ortho-phosphoric in the ratio (50:50) |
Diluent | : | Methanol |
HPLC Method Development:
HPLC Method Development and Validation: This study aimed to validate the HPLC method for quantification of reserpine and piperine as per the ICH Guidelines 12.
Instrumentation: Analysis was performed on Shimadzu prominence i-3D LC 2030 HPLC consisting of a quaternary low-pressure gradient solvent delivery pump, UV detector and an autosampler. Stationary phase of the column was Prontosil C18 (250 × 4.6 mm) SH 5.0 µm, operated at 28°C. Responses of peak area were recorded and integrated using Lab Solutions software. The wavelength maximum (λ max) was obtained by using a UV-Visible spectrophotometer.
Optimized Chromatographic Conditions: The optimized mobile phase was acetonitrile and water containing 0.05% ortho-phosphoric acid in the ratio 50:50, flow rate was kept 1 ml/min, column temperature was set at 28°C and detection wavelength was at 225 nm using a UV-visible detector.
HPLC Method Validation 12: The developed method was validated as per ICH guidelines Q2 (R1) for the parameters such as specificity, linearity, precision, accuracy, robustness, the limit of detection, and limit of quantification.
Specificity: Specificity is the ability of any analytical method to assess distinctly the analyte in the presence of components that may be presumed to be present.
Linearity: The linearity of any analytical procedure is its ability to obtain test results that are directly proportional to the concentration (amount) of analyte in the sample.
Precision: System precision and method precision were evaluated using six replicates of standard and sample solution of reserpine and piperine.
The solutions were analyzed, and percent relative standard deviation (% RSD) was calculated.
Accuracy: Recoveries of reserpine and piperine from the formulation were checked by spiking known quantity of standards i.e., 80 %, 100 % and 120 % of the quantified marker amount to the sample.
Robustness: The robustness of the developed method was evaluated by making deliberate changes in flow rate of the mobile phase (± 0.2 ml/min), column temperature (± 1°C) and wavelength (± 1 nm).
Limit of Detection (LOD): LOD of an individual analytical technique is the lowest amount of analyte in a sample which can be detected but not necessarily quantified as an exact value. LOD is determined by the formula given below.
LOD = 3.3 σ / S
Limit of Quantification (LOQ): LOQ of an individual analytical process is the lowest amount of analyte in a sample which can be quantitatively determined with suitable precision and accuracy.
LOQ = 10 σ / S
The slope (S) and standard deviation (σ) were estimated from the calibration curve of each marker.
Quantification of Markers: The concentration of two markers reserpine and piperine were estimated from marketed formulation using linear regression analysis.
RESULTS AND DISCUSSION:
Specificity: According to the established optimized chromatographic conditions, retention time (RT) of reserpine and piperine at this mobile phase was found to be 5.4 min and 13.5 min, respectively as shown in Fig. 1 and Fig. 2.
FIG. 1: CHROMATOGRAM OF MIXED STANDARD SOLUTION OF RESERPINE AND PIPERINE USING OPTIMIZED CONDITIONS
FIG. 2: CHROMATOGRAM OF EXTRACT OF MARKETED FORMULATION USING OPTIMIZED CHROMATOGRAPHIC CONDITIONS
The developed method was found to be specific as there was no interference of any other constituents at the retention time of reserpine and piperine.
Linearity: Reserpine and piperine showed linear responses in the concentration range from 1 to 20 µg/ml and 10 to 100 µg/ml as shown in Fig. 3.
The method was found to be linear as the coefficient of correlation (r2) values were found to be within the limit. The results are depicted in Table 1.
FIG. 3: CALIBRATION CURVE OF RESERPINE AND PIPERINE OBTAINED USING HPLC
TABLE 1: RESULTS OBTAINED FROM CALIBRATION CURVES OF RESERPINE AND PIPERINE
Parameters | Reserpine | Piperine |
Linearity range (µg/ml) | 1-20 µg/ml | 10-100 µg/ml |
Equation of regression line | y = 37690x + 16110 | y = 60841x - 29462 |
(r2) | 0.999 | 0.998 |
Slope | 37690 | 60841 |
Intercept | 16110 | 29462 |
Precision: The statistical analysis of the result proved that the % RSD of the peak areas obtained was less than 2, hence the developed method is found to be precise as depicted in Table 2.
TABLE 2: RESULTS OF PRECISION OF RESERPINE AND PIPERINE
System precision | Method precision | Intermediate precision | ||
% RSD | %RSD | %RSD | ||
Markers | Analyst 1 | Analyst 2 | ||
Reserpine | 0.78 | 1.07 | 0.42 | 0.75 |
Piperine | 0.76 | 0.81 | 1.2 | 1.31 |
Accuracy: The method was found to be accurate since the percent recovery was found to be within the limits as depicted in Table 3.
TABLE 3: RESULTS OF ACCURACY STUDIES FOR RESERPINE AND PIPERINE
Markers | Level of recovery (%) | Sample (µg/ml)
n=3 |
Standard added (µg/ml) | Theoretical amount
(µg/ml) |
Amount recovered
(µg/ml) |
% Recovery |
Reserpine | 80 | 7.6 | 6.0 | 13.6 | 13.48 | 99.15 |
100 | 7.6 | 7.6 | 15.2 | 14.9 | 98 | |
120 | 7.6 | 9.1 | 16.7 | 16.66 | 99.79 | |
Piperine | 80 | 376.3 | 301.04 | 677.34 | 666.56 | 98.11 |
100 | 376.3 | 376.3 | 752.60 | 744.59 | 98.9 | |
120 | 376.3 | 451.56 | 827.86 | 819.74 | 99.01 |
Robustness: The statistical analysis of the robustness results proved that the % RSD of the peak areas obtained was less than 2, hence the developed method was found to be robust. The results of robustness are depicted in Table 4.
TABLE 4: ROBUSTNESS RESULTS OF RESERPINE AND PIPERINE
Parameter | Deviation n=3 | % RSD | |||
Reserpine | Piperine | ||||
Area | RT | Area | RT | ||
Flow rate (ml/min) | 0.8 ml | 0.52 | 0.23 | 0.79 | 0.20 |
1.2 ml | 0.85 | 0.83 | 1.31 | 0.87 | |
Column temperature | 27°C | 0.95 | 0.65 | 0.55 | 0.63 |
29°C | 1.36 | 0.53 | 0.99 | 0.25 | |
Wavelength | 224 nm | 0.88 | 0.38 | 0.66 | 0.40 |
226 nm | 0.78 | 0.69 | 0.76 | 0.31 |
LOD and LOQ: LOD and LOQ of reserpine were found to be 0.16 and 0.48 µg/ml and LOD and LOQ of piperine were found to be 0.48 and 1.42 µg/ml. Low LOD and LOQ values indicate that the method is sensitive.
Quantification of Markers: Markers were quantified in the sample using linear regression analysis and the results are depicted in the Table 5.
TABLE 5: QUANTIFICATION OF MARKERS
Markers | % w/w content |
Reserpine | 0.0019 |
Piperine | 0.0940 |
Solution Stability: The solution stability of the drug substance should be evaluated since most laboratories utilize autosamplers with overnight runs.
The sample solution was injected at a different time interval and % RSD was calculated. The solution was found to be stable for 48 hours.
Summary of Results and Validation: A summary of all the results and validation obtained is given in Table 6.
TABLE 6: SUMMARY OF RESULTS OBTAINED
Sr. no. | Parameters | Levels | Results | |
Reserpine | Piperine | |||
1 | Linearity range (µg/ml) | - | 1 - 20 µg/ml | 10 - 100 µg/ml |
2 | Correlation coefficient (r2) | - | 0.999 | 0.998 |
3 | Accuracy (% recovery) | 80 % | 99.15 | 98.11 |
100 % | 98 | 98.9 | ||
120 % | 99.79 | 99.01 | ||
4 | System precision (% RSD) | - | 0.78 | 0.76 |
5 | Method precision (% RSD) | - | 1.07 | 0.81 |
6 | Intermediate precision (Ruggedness) (% RSD) | Analyst 1 | 0.42 | 1.2 |
Analyst 2 | 0.75 | 1.31 | ||
7 | Robustness (Wavelength) (% RSD) | 224 nm | 0.88 | 0.66 |
226 nm | 0.78 | 0.76 | ||
8 | Robustness (Flow rate) (% RSD) | 0.8 ml/min | 0.52 | 0.79 |
1.2 ml/min | 0.85 | 1.31 | ||
9 | Robustness (Column temperature) (% RSD) | 27ºC | 0.95 | 0.55 |
29ºC | 1.36 | 0.99 | ||
10 | Solution stability | - | The solution stability of sample solution was found to be 48 hours | |
11 | LOD (µg/ml) | 0.16 | 0.48 | |
12 | LOQ (µg/ml) | 0.48 | 1.42 |
CONCLUSION: In the present research work, a novel, simple, accurate, precise, and robust HPLC method is developed to simultaneously estimate reserpine and piperine. The developed method was applied for the standardization of a marketed polyherbal formulation. The method was validated as per the guidelines provided in ICH Q2 (R1) in terms of specificity, linearity, precision, accuracy, robustness, limit of detection, and limit of quantification. This novel developed HPLC method can be used to quantify reserpine and piperine in different herbal formulations containing Rauwolfia and Pepper as one the ingredients.
ACKNOWLEDGEMENTS: The authors are grateful to the Oriental College of Pharmacy, Sanpada, for providing facilities for research.
CONFLICTS OF INTEREST: Nil
REFERENCES:
- Tambare P, Tamboli F and More H: Standardization of herbal drugs: An overview. Inter J of Pharmacognosy and Pharmaceutical Sciences 2021; 3(1): 09- 12.
- Umamaheswari D, Muthuraja R, Kumar M and Venkateswarlu BS: Standardization of herbal drugs - An overview. International Journal of Pharmaceutical Sciences Review and Research 2021; 68(1): 213-219.
- Ramawat KG and Merillon JM: Bioactive Molecules and Medicinal Plants. Springer, Berlin, Heidelberg, First Edition 2008.
- WHO: WHO guidelines on good manufacturing practices for herbal medicines. World Health Organisation, Geneva 27 Switzerland 2007.
- Shaikh S and Jain V: Development and validation of RP-HPLC method for simultaneous determination of curcumin, piperine and camphor in an ayurvedic formulation. International Journal of Pharmacy and Pharmaceutical Sciences 2018; 10(4): 115-121.
- Shaikh HAR and Jain V: A novel, simple, rapid RP-HPLC method for simultaneous estimation of ferulic acid, quercetin, piperine and thymol in ayurvedic formulation. International Journal of Applied Pharmaceutics 2018; 10(6): 303-308.
- Sahani S and Jain V: A novel RP-HPLC method for simultaneous estimation of berberine, quercetin and piperine in an ayurvedic formulation. International Journal of Applied Pharmaceutics 2019; 11(1): 94-99.
- Peng J, Yan X, Kuang, Y, Zou D, Hu X and Sun C: HPLC determination of reserpine in compound hypotensive tablets. Editorial Office of Journal of Pharmaceutical Analysis, Thirtieth Edition 2010.
- Cheung M and Pramar M: Reserpine. Treasure Island (FL) Stat Pearls Publishing 2022.
- Li S, Liu X and Li L: A Multicenter Retrospective Analysis on Clinical Effectiveness and Economic Assessment of Compound Reserpine and Hydrochlorothiazide Tablets for Hypertension. Clinico Economics and Outcomes Research 2020; 2020 107-114.
- Tiwari A, Mahadik K and Gabhe S: Piperine: A comprehensive review of methods of isolation, purification, and biological properties. Medicine in Drug Discovery 2020; 7: 1-21.
- ICH: Validation of Analytical Procedures Text and Methodology Q2 (R1). Int Conference on Harmonisation Harmonised Tripartite Guideline 2005; 1-13.
How to cite this article:
Jaiswar UD, Patil RM and Jain VN: Novel RP-HPLC method for simultaneous estimation of reserpine and piperine in polyherbal formulation. Int J Pharm Sci & Res 2023; 14(7): 3544-49. doi: 10.13040/IJPSR.0975-8232.14(7).3544-49.
All © 2023 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
40
3544-3549
609 KB
340
English
IJPSR
U. D. Jaiswar, R. M. Patil and V. N. Jain *
Department of Quality Assurance, Oriental College of Pharmacy, Sector 2, Sanpada, Navi Mumbai, Maharashtra, India.
vandana.jain@ocp.edu.in
03 November 2022
09 January 2023
01 May 2023
10.13040/IJPSR.0975-8232.14(7).3544-49
01 July 2023